A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989
NCT04208386
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Impairment
Interventions
DRUG:
JNJ-73763989
Sponsor
Janssen Sciences Ireland UC